The Efficacy of topical Capsaicin in the management of painful diabetic peripheral neuropathy: A unicenter double-blind, randomized clinical trial
- Conditions
- Nutritional, Metabolic, Endocrine
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 22
All were patients with type 2 diabetes who had daily pain or painful paresthesias in a neuropathic or radiculopathic distribution, intensity between 4 and 7 on a visual analogic scale, interfering with daily activities, work or sleep for at least 3 months duration.
•History of allergies to any capsaicin product
•Diabetic patients with other diagnosed etiology responsible for peripheral neuropathy such as hepatitis, AIDS, Nutritional deficiencies (folate, vitamin B12)
•Presence of open skin lesions at the site of application of the study medication
•Signs of infection on limbs or amputations
•Pregnant or lactating females
•Subjects with other topical medication at site of application of study cream.
•All eligible patients who did not give their signed informed consent to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reduction in the mean pain score from baseline, as assessed by the Visual analogic scale (0-10 points).
- Secondary Outcome Measures
Name Time Method the level of improvement in quality of life score after intervention.